BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30834969)

  • 21. Supportive care needs and quality of life in patients with breast and gynecological cancer attending inpatient rehabilitation. A prospective study.
    Faller H; Hass HG; Engehausen D; Reuss-Borst M; Wöckel A
    Acta Oncol; 2019 Apr; 58(4):417-424. PubMed ID: 30632891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survivorship care plans have a negative impact on long-term quality of life and anxiety through more threatening illness perceptions in gynecological cancer patients: the ROGY care trial.
    de Rooij BH; Ezendam NPM; Nicolaije KAH; Lodder P; Vos MC; Pijnenborg JMA; Boll D; Kruitwagen RFPM; van de Poll-Franse LV
    Qual Life Res; 2018 Jun; 27(6):1533-1544. PubMed ID: 29511906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of symptomatic ascites and post-operative lymphocysts with an easy-to-use, patient-controlled, vascular catheter.
    Stukan M; Leśniewski-Kmak K; Wróblewska M; Dudziak M
    Gynecol Oncol; 2015 Mar; 136(3):466-71. PubMed ID: 25434633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life, lifestyle behavior and employment experience: a comparison between young and midlife survivors of gynecology early stage cancers.
    Bifulco G; De Rosa N; Tornesello ML; Piccoli R; Bertrando A; Lavitola G; Morra I; Di Spiezio Sardo A; Buonaguro FM; Nappi C
    Gynecol Oncol; 2012 Mar; 124(3):444-51. PubMed ID: 22119994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of the interprofessional and interdisciplinary Berlin round table on patient-reported outcomes, quality of life, and treatment expectations of patients with gynecological cancer under maintenance treatment.
    Armbrust R; Alavi S; Pirmorady A; Chen F; Colombo N; Gultekin M; Hierro C; Lemley B; Mirza MR; Urkmez E; Fotopoulou C; Vinzent J; Gonzalez Martin A; Krull A; Heepe J; Rose M; Sehouli J
    Int J Gynecol Cancer; 2020 Oct; 30(10):1603-1607. PubMed ID: 32817309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elderly ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO).
    Woopen H; Inci G; Richter R; Chekerov R; Ismaeel F; Sehouli J
    Eur J Cancer; 2016 Jun; 60():101-6. PubMed ID: 27104667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
    Penson RT; Wenzel LB; Vergote I; Cella D
    Int J Gynaecol Obstet; 2006 Nov; 95 Suppl 1():S247-57. PubMed ID: 17161164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual function and quality of life in gynecological cancer pre- and post-short-term brachytherapy: a prospective study.
    Zomkowski K; Toryi AM; Sacomori C; Dias M; Sperandio FF
    Arch Gynecol Obstet; 2016 Oct; 294(4):833-40. PubMed ID: 27117556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between patient quality of life in palliative care and burden of their family caregivers: a prospective observational cohort study.
    Krug K; Miksch A; Peters-Klimm F; Engeser P; Szecsenyi J
    BMC Palliat Care; 2016 Jan; 15():4. PubMed ID: 26767785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of leuprorelin for the treatment of recurrent gynecological cancer by assessment including self-administered quality-of-life questionnaire.
    Tsubamoto H; Ueda T; Inoue K; Isono-Nakata R; Saeki S; Kato Y; Shibahara H
    J Obstet Gynaecol Res; 2019 Jan; 45(1):203-209. PubMed ID: 30117238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient experience of non-malignant ascites and its treatment: a qualitative study.
    Day R; Hollywood C; Durrant D; Perkins P
    Int J Palliat Nurs; 2015 Aug; 21(8):372-9. PubMed ID: 26312532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015.
    Krugmann J; Schwarz CL; Melcher B; Sterlacci W; Ozalinskaite A; Lermann J; Agaimy A; Vieth M
    Arch Gynecol Obstet; 2019 Feb; 299(2):515-523. PubMed ID: 30415435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Exploration of Health-Related Quality of Life.
    Wu SF; Tong HY; Kan YY; Su SH; Lee MC; Kao CC; Lin YH
    Clin Nurs Res; 2017 Feb; 26(1):114-131. PubMed ID: 26289582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptom management in patients with cancer of the female reproductive system receiving chemotherapy.
    Phianmongkhol Y; Suwan N
    Asian Pac J Cancer Prev; 2008; 9(4):741-5. PubMed ID: 19256770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in women with gynecologic cancer in Turkey.
    Goker A; Guvenal T; Yanikkerem E; Turhan A; Koyuncu FM
    Asian Pac J Cancer Prev; 2011; 12(11):3121-8. PubMed ID: 22394001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A person-centered intervention targeting the psychosocial needs of gynecological cancer survivors: a randomized clinical trial.
    Olesen ML; Duun-Henriksen AK; Hansson H; Ottesen B; Andersen KK; Zoffmann V
    J Cancer Surviv; 2016 Oct; 10(5):832-41. PubMed ID: 26902366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of quality of life in Chinese patients with gynaecological cancer: assessments by patients and nurses.
    Zhao H; Kanda K; Liu SJ; Mao XY
    Int J Nurs Pract; 2003 Feb; 9(1):40-8. PubMed ID: 12588619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life.
    Macciò A; Madeddu C; Gramignano G; Mulas C; Floris C; Sanna E; Cau MC; Panzone F; Mantovani G
    Gynecol Oncol; 2012 Mar; 124(3):417-25. PubMed ID: 22198049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life after treatment for gynecologic malignancies: a pilot study in an outpatient clinic.
    Miller BE; Pittman B; Case D; McQuellon RP
    Gynecol Oncol; 2002 Nov; 87(2):178-84. PubMed ID: 12477448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The FACIT-AI, a new tool for assessing symptoms associated with malignant ascites.
    Cella D; Neubauer N; Thomas J; Kutner J; Seiden MV
    Gynecol Oncol; 2013 Feb; 128(2):187-90. PubMed ID: 23159815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.